medigraphic.com
ISSN 2007-6800 (Print)

2024, Number 3

<< Back Next >>

Rev Mex Traspl 2024; 13 (3)

Prevalence of reactivity to the pretransplant tuberculin skin test in suspected latent tuberculosis in renal recipients

Espinoza-Pérez R, Salgado-Román DM, Salas-Palomino IA, González-Jiménez YE, Portuguez-Peláez R, Cancino-López JD, Hernández-Díaz JC, Reyes-Díaz E, Morinelli-Astorquizaga A, Hernández-Rivera JCH

Language: Spanish
References: 24
Page: 111-115
PDF size: 302.27 Kb.


ABSTRACT

Introduction: infectious processes represent a drawback in kidney transplant patients, which is why prevention is essential, among which prophylaxis for latent tuberculosis (TB) stands out. The objective is to know the prevalence of reactivity to the tuberculin skin test in suspected latent TB in kidney recipients. Material and methods: case-control study of patients with kidney transplants, who have a tuberculin skin test (PPD). Patients are grouped into those with PPD with induration of 0 to 5 mm, 6 to 10 mm and greater than 11 mm. SPSS version 26 was used. Results: 323 transplanted patients, information was collected from 278, of which 233 patients had an induration between 0 to 4 mm, 16 transplanted with an induration between 5 to 9 mm and 29 patients with an induration of 10 or more. Median age was 37 years, interquartile range 25-75 (IQR 25-75) 29-48 years. Conclusions: the PPD test as part of patient protocolization helps in the detection of patients with probable latent TB that warrants prophylactic treatment according to the suggestions.


REFERENCES

  1. Hart A, Smith JM, Skeans MA, Gustafson SK, Stewart DE, Cherikh WS et al. Kidney. Am J Transplant. 2016; 16 Suppl 2 (Suppl 2): 11-46. doi: 10.1111/ajt.13666.

  2. Schold JD, Buccini LD, Goldfarb DA, Flechner SM, Poggio ED, Sehgal AR. Association between kidney transplant center performance and the survival benefit of transplantation versus dialysis. Clin J Am Soc Nephrol. 2014; 9 (10): 1773-1780. doi: 10.2215/CJN.02380314.

  3. Parasuraman R, Yee J, Karthikeyan V, del Busto R. Infectious complications in renal transplant recipients. Adv Chronic Kidney Dis. 2006; 13 (3): 280-294. doi: 10.1053/j.ackd.2006.04.008.

  4. Rubin RH. Infection in the organ transplant recipient. In: Rubin RH, Young LS (eds). Clinical approach to infection in the compromised host. 4th ed. New York, NY: Kluwer Academic/Plenum Publishers; 2002.

  5. Karuthu S, Blumberg EA. Common infections in kidney transplant recipients. Clin J Am Soc Nephrol. 2012; 7 (12): 2058-2070. doi: 10.2215/CJN.04410512.

  6. Tuon FF. Latent tuberculosis infection and kidney transplantation. J Bras Nefrol. 2021; 43 (4): 455-456. doi: 10.1590/2175-8239-JBN-2021-E008.

  7. Thitisuriyarax S, Vanichanan J, Udomkarnjananun S, Townamchai N, Jutivorakoll K. Factores de riesgo y resultados clínicos de la tuberculosis entre los receptores de trasplante de riñón en un país endémico alto. Transpl Infect Dis. 2021; 23 (3): e13566.

  8. Pérez RE, Gómez RR, López MC, Silva Rueda RI, Olayo RB, Díaz ER et al. Uncommon complications in the first year after renal transplantation. Transplant Proc. 2020; 52 (4): 1183-1186. doi: 10.1016/j.transproceed.2020.01.052.

  9. Hernández-Rivera JCH, García-Covarrubias L, Morinelli-Astorquizaga MA, Pérez-López MJ, Salazar-Mendoza M, Cardona Chávez JG et al. Tuberculosis abdominal en receptor de trasplante renal. Presentación de un caso y revisión de literatura. Rev Med inst Mex Seguro Soc. 2018; 56 (4): 414-417.

  10. Getahun H, Matteelli A, Abubakar I, Aziz MA, Baddeley A, Barreira D et al. Management of latent Mycobacterium tuberculosis infection: WHO guidelines for low tuberculosis burden countries. Eur Respir J. 2015; 46 (6): 1563-1576.

  11. Meinerz G, Silva CKD, Dorsdt DMB, Adames JB, Andrade JP, Ventura PE et al. Latent tuberculosis screening before kidney transplantation in the South of Brazil. J Bras Nefrol. 2021; 43 (4): 520-529. doi: 10.1590/2175-8239-JBN-2020-0189.

  12. Maciel M, Ceccato MDG, Carvalho WDS, Navarro PD, Farh KP, Miranda SS. Prevalencia de infección latente por Mycobacterium tuberculosis en receptores de trasplante renal. J Bras Pneumol. 2018; 44 (6): 461-468.

  13. Pakfetrat M, Malekmakan L, Hamidianjahromi A, Moghadami M, Khoramroz SA. Diagnosis and treatment of latent tuberculosis infection in kidney and liver transplant recipients in Iranian candidates for transplant. Exp Clin Transplant. 2022; 20 (8): 737-741. doi: 10.6002/ect.2021.0186.

  14. Bumbacea D, Arend SM, Eyuboglu F, Fishman JA, Goletti D, Ison MG et al. The risk of tuberculosis in transplant candidates and recipients: a TBNET consensus statement. Eur Respir J. 2012; 40 (4): 990-1013. doi: 10.1183/09031936.00000712.

  15. Comstock GW. How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults? Int J Tuberc Lung Dis. 1999; 3 (10): 847-850.

  16. McElroy PD, Ijaz K, Lambert LA, Jereb JA, Iademarco MF, Castro KG et al. National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection. Clin Infect Dis. 2005; 41 (8): 1125-1133. doi: 10.1086/444463.

  17. Romanowski K, Clark EG, Levin A, Cook VJ, Johnston JC. Tuberculosis and chronic kidney disease: an emerging global syndemic. Kidney Int. 2016; 90 (1): 34-40. doi: 10.1016/j.kint.2016.01.034.

  18. Kato S, Chmielewski M, Honda H, Pecoits-Filho R, Matsuo S, Yuzawa Y et al. Aspects of immune dysfunction in end-stage renal disease. Clin J Am Soc Nephrol. 2008; 3 (5): 1526-1533. doi: 10.2215/CJN.00950208.

  19. Carrero JJ, Stenvinkel P. Inflammation in end-stage renal disease--what have we learned in 10 years? Semin Dial. 2010; 23 (5): 498-509.

  20. Singh N, Paterson DL. Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management. Clin Infect Dis. 1998; 27 (5): 1266-1277.

  21. Adamu B, Abdu A, Abba AA, Borodo MM, Tleyjeh IM. Antibiotic prophylaxis for preventing post solid organ transplant tuberculosis. Cochrane Database Syst Rev. 2014; 2014 (3): CD008597. doi: 10.1002/14651858.CD008597.pub2.

  22. Aguado JM, Torre-Cisneros J, Fortún J, Benito N, Meije Y, Doblas A et al. Tuberculosis in solid-organ transplant recipients: consensus statement of the group for the study of infection in transplant recipients (GESITRA) of the Spanish Society of Infectious Diseases and Clinical Microbiology. Clin Infect Dis. 2009; 48 (9): 1276-1284.

  23. Subramanian A, Dorman S; AST Infectious Diseases Community of Practice. Mycobacterium tuberculosis in solid organ transplant recipients. Am J Transplant. 2009; 9 Suppl 4: S57-S62.

  24. Klote MM, Agodoa LY, Abbott K. Mycobacterium tuberculosis infection incidence in hospitalized renal transplant patients in the United States, 1998-2000. Am J Transplant. 2004; 4 (9): 1523-1528.




2020     |     www.medigraphic.com